Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2003 Sep;58(9):809–813. doi: 10.1136/thorax.58.9.809

Lung cancer • 8: Management of malignant mesothelioma

C Parker 1, E Neville 1
PMCID: PMC1746789  PMID: 12947146

Full Text

The Full Text of this article is available as a PDF (112.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams R. F., Gray W., Davies R. J., Gleeson F. V. Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma. Chest. 2001 Dec;120(6):1798–1802. doi: 10.1378/chest.120.6.1798. [DOI] [PubMed] [Google Scholar]
  2. Alberts A. S., Falkson G., Goedhals L., Vorobiof D. A., Van der Merwe C. A. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol. 1988 Mar;6(3):527–535. doi: 10.1200/JCO.1988.6.3.527. [DOI] [PubMed] [Google Scholar]
  3. Antman K. H., Pomfret E. A., Aisner J., MacIntyre J., Osteen R. T., Greenberger J. S. Peritoneal mesothelioma: natural history and response to chemotherapy. J Clin Oncol. 1983 Jun;1(6):386–391. doi: 10.1200/JCO.1983.1.6.386. [DOI] [PubMed] [Google Scholar]
  4. Astoul P. Pleural mesothelioma. Curr Opin Pulm Med. 1999 Jul;5(4):259–268. doi: 10.1097/00063198-199907000-00015. [DOI] [PubMed] [Google Scholar]
  5. Baas P., Schouwink H., Zoetmulder F. A. Malignant pleural mesothelioma. Ann Oncol. 1998 Feb;9(2):139–149. doi: 10.1023/a:1008239116237. [DOI] [PubMed] [Google Scholar]
  6. Baldini E. H., Recht A., Strauss G. M., DeCamp M. M., Jr, Swanson S. J., Liptay M. J., Mentzer S. J., Sugarbaker D. J. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg. 1997 Feb;63(2):334–338. doi: 10.1016/s0003-4975(96)01228-3. [DOI] [PubMed] [Google Scholar]
  7. Bissett D., Macbeth F. R., Cram I. The role of palliative radiotherapy in malignant mesothelioma. Clin Oncol (R Coll Radiol) 1991 Nov;3(6):315–317. doi: 10.1016/s0936-6555(05)80582-5. [DOI] [PubMed] [Google Scholar]
  8. Bloom A. I., Wilson M. W., Kerlan R. K., Jr, Gordon R. L., LaBerge J. M. Talc pleurodesis through small-bore percutaneous tubes. Cardiovasc Intervent Radiol. 1999 Sep-Oct;22(5):433–436. doi: 10.1007/s002709900422. [DOI] [PubMed] [Google Scholar]
  9. Boutin C., Irisson M., Rathelot P., Petite J. M. L'extension pariétale des mésothéliomes pleuraux malins diffus après biopsies. Prévention par radiothérapie locale. Presse Med. 1983 Jul 9;12(29):1823–1823. [PubMed] [Google Scholar]
  10. Boutin C., Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer. 1993 Jul 15;72(2):389–393. doi: 10.1002/1097-0142(19930715)72:2<389::aid-cncr2820720213>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  11. Boutin C., Rey F., Viallat J. R. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest. 1995 Sep;108(3):754–758. doi: 10.1378/chest.108.3.754. [DOI] [PubMed] [Google Scholar]
  12. Boutin C., Schlesser M., Frenay C., Astoul P. Malignant pleural mesothelioma. Eur Respir J. 1998 Oct;12(4):972–981. doi: 10.1183/09031936.98.12040972. [DOI] [PubMed] [Google Scholar]
  13. Brady L. W. Mesothelioma--the role for radiation therapy. Semin Oncol. 1981 Sep;8(3):329–334. [PubMed] [Google Scholar]
  14. Browne K., Smither W. J. Asbestos-related mesothelioma: factors discriminating between pleural and peritoneal sites. Br J Ind Med. 1983 May;40(2):145–152. doi: 10.1136/oem.40.2.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bruera E. Pharmacological treatment of cachexia: any progress? Support Care Cancer. 1998 Mar;6(2):109–113. doi: 10.1007/s005200050143. [DOI] [PubMed] [Google Scholar]
  16. Butchart E. G., Ashcroft T., Barnsley W. C., Holden M. P. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax. 1976 Feb;31(1):15–24. doi: 10.1136/thx.31.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Calavrezos A., Koschel G., Hüsselmann H., Taylessani A., Heilmann H. P., Fabel H., Schmoll H. J., Dietrich H., Hain E. Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981-1985. Klin Wochenschr. 1988 Jul 15;66(14):607–613. doi: 10.1007/BF01728801. [DOI] [PubMed] [Google Scholar]
  18. Ceresoli G. L., Locati L. D., Ferreri A. J., Cozzarini C., Passoni P., Melloni G., Zannini P., Bolognesi A., Villa E. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer. 2001 Nov;34(2):279–287. doi: 10.1016/s0169-5002(01)00257-4. [DOI] [PubMed] [Google Scholar]
  19. Davis J. M., Addison J., Bolton R. E., Donaldson K., Jones A. D., Smith T. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol. 1986 Jun;67(3):415–430. [PMC free article] [PubMed] [Google Scholar]
  20. Davis S. R., Tan L., Ball D. L. Radiotherapy in the treatment of malignant mesothelioma of the pleura, with special reference to its use in palliation. Australas Radiol. 1994 Aug;38(3):212–214. doi: 10.1111/j.1440-1673.1994.tb00177.x. [DOI] [PubMed] [Google Scholar]
  21. Elmes P. C., Simpson J. C. The clinical aspects of mesothelioma. Q J Med. 1976 Jul;45(179):427–449. [PubMed] [Google Scholar]
  22. Gardner M. J., Jones R. D., Pippard E. C., Saitoh N. Mesothelioma of the peritoneum during 1967-82 in England and Wales. Br J Cancer. 1985 Jan;51(1):121–126. doi: 10.1038/bjc.1985.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Genc O., Petrou M., Ladas G., Goldstraw P. The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions. Eur J Cardiothorac Surg. 2000 Aug;18(2):143–146. doi: 10.1016/s1010-7940(00)00422-x. [DOI] [PubMed] [Google Scholar]
  24. Gibbs A. R. Role of asbestos and other fibres in the development of diffuse malignant mesothelioma. Thorax. 1990 Sep;45(9):649–654. doi: 10.1136/thx.45.9.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Girling David J., Muers Martin F., Qian Wendi, Lobban Dawn. Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council. Semin Oncol. 2002 Feb;29(1):97–101. doi: 10.1053/sonc.2002.30235. [DOI] [PubMed] [Google Scholar]
  26. Gordon W., Jr, Antman K. H., Greenberger J. S., Weichselbaum R. R., Chaffey J. T. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys. 1982 Jan;8(1):19–25. doi: 10.1016/0360-3016(82)90379-0. [DOI] [PubMed] [Google Scholar]
  27. Gordon W., Jr, Antman K. H., Greenberger J. S., Weichselbaum R. R., Chaffey J. T. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys. 1982 Jan;8(1):19–25. doi: 10.1016/0360-3016(82)90379-0. [DOI] [PubMed] [Google Scholar]
  28. Gravelyn T. R., Michelson M. K., Gross B. H., Sitrin R. G. Tetracycline pleurodesis for malignant pleural effusions. A 10-year retrospective study. Cancer. 1987 Jun 1;59(11):1973–1977. doi: 10.1002/1097-0142(19870601)59:11<1973::aid-cncr2820591124>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  29. Hansen M., Faurschou P., Clementsen P. Medical thoracoscopy, results and complications in 146 patients: a retrospective study. Respir Med. 1998 Feb;92(2):228–232. doi: 10.1016/s0954-6111(98)90100-7. [DOI] [PubMed] [Google Scholar]
  30. Hartman D. L., Gaither J. M., Kesler K. A., Mylet D. M., Brown J. W., Mathur P. N. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J Thorac Cardiovasc Surg. 1993 Apr;105(4):743–748. [PubMed] [Google Scholar]
  31. Heelan R. T. CT and MR imaging in the evaluation of pleural masses. Chest Surg Clin N Am. 1994 Aug;4(3):431–450. [PubMed] [Google Scholar]
  32. Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest. 1983 Oct;77(4):321–343. [PubMed] [Google Scholar]
  33. Hubbard R. The aetiology of mesothelioma: are risk factors other than asbestos exposure important? Thorax. 1997 Jun;52(6):496–497. doi: 10.1136/thx.52.6.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Häkkinen A. M., Laasonen A., Linnainmaa K., Mattson K., Pyrhönen S. Radiosensitivity of mesothelioma cell lines. Acta Oncol. 1996;35(4):451–456. doi: 10.3109/02841869609109921. [DOI] [PubMed] [Google Scholar]
  35. Ischia S., Ischia A., Luzzani A., Toscano D., Steele A. Results up to death in the treatment of persistent cervico-thoracic (Pancoast) and thoracic malignant pain by unilateral percutaneous cervical cordotomy. Pain. 1985 Apr;21(4):339–355. doi: 10.1016/0304-3959(85)90163-0. [DOI] [PubMed] [Google Scholar]
  36. Jackson M. B., Pounder D., Price C., Matthews A. W., Neville E. Percutaneous cervical cordotomy for the control of pain in patients with pleural mesothelioma. Thorax. 1999 Mar;54(3):238–241. doi: 10.1136/thx.54.3.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kennedy L., Sahn S. A. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest. 1994 Oct;106(4):1215–1222. doi: 10.1378/chest.106.4.1215. [DOI] [PubMed] [Google Scholar]
  38. Kessinger A., Wigton R. S. Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study. J Surg Oncol. 1987 Oct;36(2):81–83. doi: 10.1002/jso.2930360202. [DOI] [PubMed] [Google Scholar]
  39. Lahuerta J., Bowsher D., Lipton S., Buxton P. H. Percutaneous cervical cordotomy: a review of 181 operations on 146 patients with a study on the location of "pain fibers" in the C-2 spinal cord segment of 29 cases. J Neurosurg. 1994 Jun;80(6):975–985. doi: 10.3171/jns.1994.80.6.0975. [DOI] [PubMed] [Google Scholar]
  40. Law M. R., Hodson M. E., Heard B. E. Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax. 1982 Nov;37(11):810–815. doi: 10.1136/thx.37.11.810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Layer G., van Kaick G. Mesotheliom der Pleura--Diagnostik durch bildgebende Verfahren. Langenbecks Arch Chir Suppl Kongressbd. 1992:173–179. [PubMed] [Google Scholar]
  42. Lee Y. C., Light R. W., Musk A. W. Management of malignant pleural mesothelioma: a critical review. Curr Opin Pulm Med. 2000 Jul;6(4):267–274. doi: 10.1097/00063198-200007000-00003. [DOI] [PubMed] [Google Scholar]
  43. Leung A. N., Müller N. L., Miller R. R. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol. 1990 Mar;154(3):487–492. doi: 10.2214/ajr.154.3.2106209. [DOI] [PubMed] [Google Scholar]
  44. Little A. G., Kadowaki M. H., Ferguson M. K., Staszek V. M., Skinner D. B. Pleuro-peritoneal shunting. Alternative therapy for pleural effusions. Ann Surg. 1988 Oct;208(4):443–450. doi: 10.1097/00000658-198810000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Low E. M., Khoury G. G., Matthews A. W., Neville E. Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy. Clin Oncol (R Coll Radiol) 1995;7(5):317–318. doi: 10.1016/s0936-6555(05)80540-0. [DOI] [PubMed] [Google Scholar]
  46. Markman M., Cleary S., Pfeifle C., Howell S. B. Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma. Cancer. 1986 Jul 1;58(1):18–21. doi: 10.1002/1097-0142(19860701)58:1<18::aid-cncr2820580105>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  47. Marom E. M., Patz E. F., Jr, Erasmus J. J., McAdams H. P., Goodman P. C., Herndon J. E. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology. 1999 Jan;210(1):277–281. doi: 10.1148/radiology.210.1.r99dc04277. [DOI] [PubMed] [Google Scholar]
  48. Middleton G. W., Smith I. E., O'Brien M. E., Norton A., Hickish T., Priest K., Spencer L., Ashley S. Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma. Ann Oncol. 1998 Mar;9(3):269–273. doi: 10.1023/a:1008236010868. [DOI] [PubMed] [Google Scholar]
  49. Moertel C. G. Peritoneal mesothelioma. Gastroenterology. 1972 Aug;63(2):346–350. [PubMed] [Google Scholar]
  50. Moskal T. L., Urschel J. D., Anderson T. M., Antkowiak J. G., Takita H. Malignant pleural mesothelioma: a problematic review. Surg Oncol. 1998 Jul-Aug;7(1-2):5–12. doi: 10.1016/s0960-7404(98)00019-x. [DOI] [PubMed] [Google Scholar]
  51. Ong S. T., Vogelzang N. J. Chemotherapy in malignant pleural mesothelioma. A review. J Clin Oncol. 1996 Mar;14(3):1007–1017. doi: 10.1200/JCO.1996.14.3.1007. [DOI] [PubMed] [Google Scholar]
  52. Parker L. A., Charnock G. C., Delany D. J. Small bore catheter drainage and sclerotherapy for malignant pleural effusions. Cancer. 1989 Sep 15;64(6):1218–1221. doi: 10.1002/1097-0142(19890915)64:6<1218::aid-cncr2820640609>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  53. Patz E. F., Jr, Shaffer K., Piwnica-Worms D. R., Jochelson M., Sarin M., Sugarbaker D. J., Pugatch R. D. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol. 1992 Nov;159(5):961–966. doi: 10.2214/ajr.159.5.1414807. [DOI] [PubMed] [Google Scholar]
  54. Peto J., Decarli A., La Vecchia C., Levi F., Negri E. The European mesothelioma epidemic. Br J Cancer. 1999 Feb;79(3-4):666–672. doi: 10.1038/sj.bjc.6690105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Peto J., Hodgson J. T., Matthews F. E., Jones J. R. Continuing increase in mesothelioma mortality in Britain. Lancet. 1995 Mar 4;345(8949):535–539. doi: 10.1016/s0140-6736(95)90462-x. [DOI] [PubMed] [Google Scholar]
  56. Pien G. W., Gant M. J., Washam C. L., Sterman D. H. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest. 2001 Jun;119(6):1641–1646. doi: 10.1378/chest.119.6.1641. [DOI] [PubMed] [Google Scholar]
  57. Putnam J. B., Jr, Light R. W., Rodriguez R. M., Ponn R., Olak J., Pollak J. S., Lee R. B., Payne D. K., Graeber G., Kovitz K. L. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999 Nov 15;86(10):1992–1999. [PubMed] [Google Scholar]
  58. Renshaw A. A., Dean B. R., Antman K. H., Sugarbaker D. J., Cibas E. S. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest. 1997 Jan;111(1):106–109. doi: 10.1378/chest.111.1.106. [DOI] [PubMed] [Google Scholar]
  59. Ribak J., Selikoff I. J. Survival of asbestos insulation workers with mesothelioma. Br J Ind Med. 1992 Oct;49(10):732–735. doi: 10.1136/oem.49.10.732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Rinaldo J. E., Owens G. R., Rogers R. M. Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg. 1983 Apr;85(4):523–526. [PubMed] [Google Scholar]
  61. Rosomoff H. L., Brown C. J., Sheptak P. Percutaneous radiofrequency cervical cordotomy: technique. J Neurosurg. 1965 Dec;23(6):639–644. doi: 10.3171/jns.1965.23.6.0639. [DOI] [PubMed] [Google Scholar]
  62. Ross E. L. The evolving role of antiepileptic drugs in treating neuropathic pain. Neurology. 2000;55(5 Suppl 1):S41–S58. [PubMed] [Google Scholar]
  63. Rusch V. W. A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer. 1996 Feb;14(1):1–12. doi: 10.1016/0169-5002(95)00508-0. [DOI] [PubMed] [Google Scholar]
  64. Rusch V. W., Piantadosi S., Holmes E. C. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg. 1991 Jul;102(1):1–9. [PubMed] [Google Scholar]
  65. Rusch V. W., Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 1996 Apr;111(4):815–826. doi: 10.1016/s0022-5223(96)70342-2. [DOI] [PubMed] [Google Scholar]
  66. Ryan C. W., Herndon J., Vogelzang N. J. A review of chemotherapy trials for malignant mesothelioma. Chest. 1998 Jan;113(1 Suppl):66S–73S. doi: 10.1378/chest.113.1_supplement.66s. [DOI] [PubMed] [Google Scholar]
  67. Sahin U., Unlü M., Akkaya A., Ornek Z. The value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions. Respiration. 2001;68(5):501–505. doi: 10.1159/000050558. [DOI] [PubMed] [Google Scholar]
  68. Sahn S. A. Management of malignant pleural effusions. Monaldi Arch Chest Dis. 2001 Oct;56(5):394–399. [PubMed] [Google Scholar]
  69. Sahn S. A. Pleural effusion in lung cancer. Clin Chest Med. 1993 Mar;14(1):189–200. [PubMed] [Google Scholar]
  70. Seaton K. G., Patz E. F., Jr, Goodman P. C. Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy. AJR Am J Roentgenol. 1995 Mar;164(3):589–591. doi: 10.2214/ajr.164.3.7532350. [DOI] [PubMed] [Google Scholar]
  71. Solomons K. Malignant mesothelioma--clinical and epidemiological features. A report of 80 cases. S Afr Med J. 1984 Sep 15;66(11):407–412. [PubMed] [Google Scholar]
  72. Stanton M. F., Layard M., Tegeris A., Miller E., May M., Morgan E., Smith A. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst. 1981 Nov;67(5):965–975. [PubMed] [Google Scholar]
  73. Sterman D. H., Kaiser L. R., Albelda S. M. Advances in the treatment of malignant pleural mesothelioma. Chest. 1999 Aug;116(2):504–520. doi: 10.1378/chest.116.2.504. [DOI] [PubMed] [Google Scholar]
  74. Sugarbaker D. J., Flores R. M., Jaklitsch M. T., Richards W. G., Strauss G. M., Corson J. M., DeCamp M. M., Jr, Swanson S. J., Bueno R., Lukanich J. M. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999 Jan;117(1):54–65. doi: 10.1016/s0022-5223(99)70469-1. [DOI] [PubMed] [Google Scholar]
  75. Sugarbaker D. J., Garcia J. P., Richards W. G., Harpole D. H., Jr, Healy-Baldini E., DeCamp M. M., Jr, Mentzer S. J., Liptay M. J., Strauss G. M., Swanson S. J. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg. 1996 Sep;224(3):288–296. doi: 10.1097/00000658-199609000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Sugarbaker D. J., Strauss G. M., Lynch T. J., Richards W., Mentzer S. J., Lee T. H., Corson J. M., Antman K. H. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol. 1993 Jun;11(6):1172–1178. doi: 10.1200/JCO.1993.11.6.1172. [DOI] [PubMed] [Google Scholar]
  77. Van Gelder T., Damhuis R. A., Hoogsteden H. C. Prognostic factors and survival in malignant pleural mesothelioma. Eur Respir J. 1994 Jun;7(6):1035–1038. [PubMed] [Google Scholar]
  78. WAGNER J. C., SLEGGS C. A., MARCHAND P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960 Oct;17:260–271. doi: 10.1136/oem.17.4.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Walker-Renard P. B., Vaughan L. M., Sahn S. A. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994 Jan 1;120(1):56–64. doi: 10.7326/0003-4819-120-1-199401010-00010. [DOI] [PubMed] [Google Scholar]
  80. Waller D. A., Morritt G. N., Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest. 1995 May;107(5):1454–1456. doi: 10.1378/chest.107.5.1454. [DOI] [PubMed] [Google Scholar]
  81. Watson P. N., Evans R. J. Intractable pain with lung cancer. Pain. 1987 May;29(2):163–173. doi: 10.1016/0304-3959(87)91033-5. [DOI] [PubMed] [Google Scholar]
  82. Whitaker D., Shilkin K. B. Diagnosis of pleural malignant mesothelioma in life--a practical approach. J Pathol. 1984 Jul;143(3):147–175. doi: 10.1002/path.1711430303. [DOI] [PubMed] [Google Scholar]
  83. Wiffen P., Collins S., McQuay H., Carroll D., Jadad A., Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2000;(3):CD001133–CD001133. doi: 10.1002/14651858.CD001133. [DOI] [PubMed] [Google Scholar]
  84. Yates D. H., Corrin B., Stidolph P. N., Browne K. Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax. 1997 Jun;52(6):507–512. doi: 10.1136/thx.52.6.507. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES